Skip to main content

LIVE

LIN

Linde plc

LIN

NASDAQ·Basic Materials·Chemicals - Specialty·Mkt cap $220.9B

$477.57

-0.96%

P/E

30.81

Mkt Cap

$220.9B

52-Wk Range

$387.78–$548.20

52-Week Range

$387.78 - $548.20

P/E

30.81

Fwd P/E

26.71

Beta

0.73

Div Yield

1.32%

Avg Vol

2.2M

Shares Out

462.6M

Mkt Cap

$220.9B

Price action

Price chart

Up 0.6% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

5 reasons

  • Global scale and distribution network with 145+ years of operational history
  • Integrated business model combining gas production with engineering expertise
  • High switching costs and long-term customer contracts in essential industries
  • Technological leadership in gas separation and specialty gas production
  • Diversified customer base across 400,000+ accounts spanning multiple industries

Bear Case

2 risks

  • Low volatility (beta 0.7).
  • Premium valuation to Specialty Chemicals peers

Growth

Stable outlook

Increasing demand for hydrogen as clean energy transition accelerates

Value

Premium valuation to Specialty Chemicals peers

Momentum

Stable

-4.8% over 3m

Quality

Strong

Strong fundamentals

Dividend

Modest

1.32% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Oct 30, 2026

Q3 26 RECAP

JUL 31, 2026

Reported EPS of $4.50 vs $4.49 consensus (+0.2% surprise). Revenue of $9.3B vs $9.0B expected (+3.0%). Beat on both top and bottom lines.

EPS beat +0.2%
Rev beat +3.0%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+0.2%

Revenue trend · last 8Q

-0%

+0%

+3%

+3%

+6%

+8%

+9%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$8.4B

$8.3B

$8.1B

$8.5B

$8.6B

$8.8B

$8.8B

$9.3B

Margins · last 8Q

Gross

0.0%

Operating

27.5%

Profit

20.8%

Wall Street consensus

7 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

7

100%

Hold

0%

Sell

0%

Median Price Target

Latest: UBS · Sep 4, 2026

vs Industry

How LIN stacks vs Chemicals - Specialty

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.